与非黑素瘤皮肤癌高龄老人预期寿命有限相关的共病评分
回顾性分析488例85岁及以上接受非黑素瘤皮肤癌管理的患者,采用ACE-27和ACCI共病评分,发现两评分与总生存相关,分别≥3分和≥7分时4年生存率低于50%;接受Mohs显微描记手术者中位生存较未接受者长20个月。
要点
- ACE-27评分≥3分或ACCI评分≥7分与4年生存率低于50%相关。
- 接受Mohs显微描记手术的患者中位生存时间比未接受者长20个月。
- 仅凭年龄和共病不足以决定高龄非黑素瘤皮肤癌的治疗。
核心结论
- ACE-27和ACCI评分可预测预期寿命有限。
- 接受Mohs显微描记手术的队列生存改善,尽管队列间共病相似,提示其他因素也影响生存,仅凭年龄和共病不足以做出高龄非黑素瘤皮肤癌治疗决策。
研究设计与样本
- 回顾性综述,纳入1999年7月至2014年12月间因非黑素瘤皮肤癌就诊的488例85岁及以上患者,采用ACE-27和ACCI进行共病评分并确定死亡日期、随访和总生存。
主要发现
- ACE-27和ACCI评分与总生存相关;ACE-27评分3分和ACCI评分7分及以上时,4年生存率均低于50%。
- 接受Mohs显微描记手术的患者中位生存时间比未接受者长20个月。
关键数值与推荐
- ACE-27评分3分与4年生存率低于50%相关。
- ACCI评分7分及以上与4年生存率低于50%相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 回顾性研究设计。
- 转诊偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is controversy regarding treatment of nonmelanoma skin cancer (NMSC) in very elderly individuals, with some suggesting that this population may not live long enough to benefit from invasive treatments. Tools to assess limited life expectancy (LLE) exist, but performance in the population of very elderly individuals with NMSC has not been well defined. OBJECTIVE: Define comorbidity scores associated with LLE in very elderly individuals presenting for management of NMSC. METHODS: A retrospective review of 488 patients age 85 or older presenting for NMSC management between July 1999 through December 2014 was performed. Comorbidities were scored by using the Adult Comorbidity Evaluation-27 (ACE-27) and age-adjusted Charlson comorbidity index (ACCI). Dates of death, follow-up, and overall survival were determined. RESULTS: ACE-27 and ACCI scores were associated with overall survival; at scores of 3 and 7+, respectively, both were associated with less than 50% survival at 4 years. Patients who underwent Mohs micrographic surgery survived a median of 20 months longer than patients who did not. LIMITATIONS: Retrospective study design and referral bias. CONCLUSIONS: ACE-27 and ACCI scores predicted LLE. The cohort presenting for Mohs micrographic surgery had improved survival, despite similar intercohort comorbidity. This suggests that additional factors contributed to survival and that age and comorbidities alone are inadequate for making NMSC treatment decisions in very elderly individuals.
引用
- Rogers EM, Connolly KL, Nehal KS, et al. Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer. J Am Acad Dermatol. 2017. PMID: 29288096. doi:10.1016/j.jaad.2017.12.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。